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Diagnosis of PRRS
Abstract
A panel of seven different groups of monoclonal antibodies (Mabs) specific for the 15 kD nucleocapsid
protein of porcine reproductive and respiratory syndrome virus (PRRSV) was generated from mice that were
immunized with antigens derived from PRRSV isolate ATCC VR-2402 (ISU-P). These groups, designated A
through B, were determined by their reactivity in the IFA to 67 different field isolates representing 13
states,Canada,the European Lelystad virus and the current North American vaccine strain, ATCC VR-2332.
The field isolates were collected during 1989 through 1995. Group A Mab’s reacted with all field isolates and
the Lelystad virus and as such should be considered for use as universal diagnostic Mab’s for PRRSV. The field
isolates and the Lelystad virus were able to be categorized into seven distinct groups (I-VII) based on their
reactivity to the panel of Mab’s. Group I represented 56 isolates. The six remaining groups were represented by
one to four field isolates each. These observations demonstrate that there is a wider degree of diversity among
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Summary and Implication
A panel of seven different groups of monoclonal
antibodies (Mabs) specific for the 15 kD nucleocapsid
protein of porcine reproductive and respiratory syndrome
virus (PRRSV)  was generated from mice that were
immunized with antigens derived from PRRSV isolate
ATCC VR-2402 (ISU-P). These groups, designated A
through B, were determined by their reactivity in the IFA to
67 different field isolates representing 13 states,Canada,the
European Lelystad virus and the current North American
vaccine strain, ATCC VR-2332. The field isolates were
collected during 1989 through 1995.  Group A MabÕs reacted
with all field isolates and the Lelystad virus and as such
should be considered for use as  universal diagnostic MabÕs
for PRRSV. The field isolates and the Lelystad virus were
able to be categorized into seven distinct groups (I-VII) based
on their reactivity to the panel of MabÕs.  Group I
represented 56 isolates.  The six remaining groups were
represented by one to four field isolates each. These
observations demonstrate that there is a wider degree of
diversity among North American PRRSV isolates then was
previously believed. 
Introduction
Porcine reproductive and respiratory syndrome (PRRS)
is an economically important viral disease of swine caused
by a small, enveloped RNA virus of the family Arteriviridae
(4). Clinical manifestations of PRRSV infection are
characterized by reproductive failure in sows and gilts,
respiratory disease in young growing pigs, and increased
mortality in pre-weaning pigs (2, 6).
Antigenic variation among PRRSV isolates was first
demonstrated between North American and European
PRRSV isolates by the immunoperoxidase monolayer assay
using PRRSV specific polyclonal antibodies (1, 7). Similar
antigenic variation between European and North American
isolates has also been shown by the indirect fluorescent
antibody (IFA) test using three different monoclonal
antibodies specific for the 15 kD nucleocapsid protein (3, 5).
 While these earlier studies demonstrated that antigenic
differences exist between European and North American
PRRSV isolates, they failed to demonstrate significant
antigenic variation among North American isolates.  This
led to the routine use of a single Mab for the diagnosis of
PRRV in clinical specimens.  Subsequently work in this
laboratory suggested  that North American PRRSV isolates
were more antigenically diversified than previously believed
and that the antibodies currently in use for diagnostic
purposes did not detect all field isolates (8).  These
observations led to the following study in which
monoclonal antibodies were developed that could be used for
the detection of PRRSV in clinical specimens with a higher
degree of reliability. 
Materials and Methods
Virus
A total of 67 PRRSV field isolates  representing 13
states,Canada,the European Lelystad virus and the current
North American vaccine strain and  ATCC VR-2332 also
known as ISU-P were used in the study.  The field strains
were derived from clinical specimens submitted to the
National Veterinary Services Laboratories,
USDA/APHIS/VS, Ames, Iowa, the Rollins Animal
Disease Laboratory, Raleigh, North Carolina and the Iowa
State Veterinary Diagnostic Laboratory, Ames, IA  during
1989 though 1996. 
Isolate ISU-P was used  to produce antigen for mouse
immunization in the production of Mab, and for the IFA
test. This isolate was obtained from a swine herd in the state
of Illinois with clinical PRRS
Production of monoclonal antibody specific for PRRSV    
Murine monoclonal antibodies were produced using a
standard protocol.   Antibody producing hybridoma cells 
were identified by screening cell supernatant with  an
enzyme-linked immunosorbent assay and a FA test  using 
MA104 cells infected with isolate ISU-P as antigen. 
Antibody- secreting hybridomas were cloned twice by a cell
sorter. Classes and subclasses of individual MAbs were
determined using a mouse monoclonal antibody isotyping
kit (Boehringer Mannheim¨).  The  specificity of MabÕs was
determined by Western immunoblotting. A standard serum
virus neutralizing assay was used to determine if MabÕs were
capable of neutralizing virus.    
Catagorization of monoclonal antibodies and field isolates
All 67 PRRSV isolates were  tested in duplicate for
reactivity with each Mab in the IFA on three separate days. 
The patterns of reactivity were then used to categorize both
virus isolates and MabÕs into distinct groups. 
 
Results and Discussion
All of 22 MAbs generated were IgG1 and specific for
the 15 kD protein of PRRSV. No Mab had neutralizing
activity against PRRSV isolate ISU-P, the isolate used in
producing the MabÕs.
The categorization of Mabs and PRRSV isolates into
specific groups is summarized in Table 1. Seven distinct
groups (A-G) of Mabs were identified based on their
reactivity with different PRRSV isolates in the IFA test.  
Group A Mabs reacted with all of the 67 isolates tested
which suggests that these Mabs can be used as universal
diagnostic Mabs. In contrast the European Lelystad virus,
Group VII, is recognized only by GroupA and Group D
Mab.
The 67 PRRSV field isolates were categorized into
seven groups (I-VII). Fifty six of the 67 isolates (83.6%)
belong to Group I.  This group of viruses was  recognized
by all Mabs tested. The ATCC VR-2332, prototype vaccine
strain and the ISU-P isolate are also included in this Group.
 The number of viruses represented by the remaining Groups
range from one to four. These observations demonstrate that
North American PRRSV isolates are antigenically more
diverse than previously believed. 
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Table 1. The reactivity of 22 monoclonal antibodies to 67 PRRSV isolates in indirect
fluorescent antibody test.
                PRRS virus                          Group of Monoclonalantibodies   
Group No. of isolate A B C D E F G
I   56* + + + + + + +
II   1 + + + + + + -
III   1 + + + + + - +
IV   2 + + + - - + +
V   4 + + - - - + +
VI   2 + + - - + - +
VII   1 + - - + - - -
67 B5à A23 G6 J2 H1 G9 D12
*number of PRRS virus isolates catagorized to antigenic group
àrepresentative monoclonal antibody of group
